VasThera is an innovative pharmaceutical company that develops
the first-in-class synthetic therapeutics targeting the vascular
hyperplasia, with a primary focus in pulmonary arterial
hypertension (PAH) and other cardiovascular diseases(CVD),
i.e. restenosis and atherosclerosis.